CBT Stock Recent News
CBT LATEST HEADLINES
Here is how Cabot (CBT) and Centerra Gold Inc. (CGAU) have performed compared to their sector so far this year.
Cabot (CBT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Cabot Corporation (NYSE:CBT ) Q3 2024 Earnings Conference Call August 6, 2024 8:00 AM ET Company Participants Steve Delahunt – Vice President, Treasurer and Investor Relations Sean Keohane – Chief Executive Officer and President Erica McLaughlin – Executive Vice President and Chief Financial Officer Conference Call Participants John Roberts – Mizuho David Begleiter – Deutsche Bank Josh Spector – UBS Jeff Zekauskas – JPMorgan Operator Good day. Thank you for standing by.
Cabot's (CBT) top line increases in the fiscal third quarter on higher sales across its segments.
Cabot (CBT) came out with quarterly earnings of $1.92 per share, beating the Zacks Consensus Estimate of $1.74 per share. This compares to earnings of $1.42 per share a year ago.
Eastman Chemical, Cabot and Kronos Worldwide have been highlighted in this Industry Outlook article.
Demand softness in specific markets, de-stocking and the slowdown in China and Europe pose headwinds for the Zacks Chemicals Diversified industry. EMN, CBT and KRO are poised to navigate the industry challenges.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Walmart (WMT), Agnico Eagle (AEM), Booz Allen Hamilton (BAH), Vertiv Holdings (VRT) and Cabot (CBT) could be compelling picks given their history of dividend increase.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.